Family history of cancer and gastroesophageal disorders and risk of esophageal and gastric adenocarcinomas: A case-control study

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Jiang, Xuejuan ^a   Tseng, Chiu Chen ^b   Bernstein, Leslie ^c   Wu, Anna H ^d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Distal gastric cancer; Esophageal adenocarcinoma, Gastric cardia; Family history; Hiatal hernia

Indexed keywords

ADENOCARCINOMA; AGE OF ONSET; AGED; CASE-CONTROL STUDIES; ENVIRONMENT; ESOPHAGEAL NEOPLASMS; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HEREDITY; HERNIA, HIATAL; HUMANS; LOGISTIC MODELS; LOS ANGELES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PEDIGREE; PROSTATIC NEOPLASMS; RISK FACTORS; SEER PROGRAM; STOMACH NEOPLASMS;

EID: 84893192140     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-60     Document Type: Article

References (41)

1. Crew KD, Neugut AI. Epidemiology of upper gastrointestinal malignancies. Semin Oncol 2004, 31(4):450-464. 10.1053/j.seminoncol.2004.04.021, 15297938.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90. 10.3322/caac.20107, 21296855.
3. Hoyo C, Cook MB, Kamangar F, Freedman ND, Whiteman DC, Bernstein L, Brown LM, Risch HA, Ye W, Sharp L, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol 2012, 41(6):1706-1718. 10.1093/ije/dys176, 3535758, 23148106.
4. Lao-Sirieix P, Caldas C, Fitzgerald RC. Genetic predisposition to gastro-oesophageal cancer. Curr Opin Genet Dev 2010, 20(3):210-217. 10.1016/j.gde.2010.03.002, 20347291.
5. Dikken JL, Lemmens VE, Wouters MW, Wijnhoven BP, Siersema PD, Nieuwenhuijzen GA, van Sandick JW, Cats A, Verheij M, Coebergh JW, et al. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. Eur J Cancer 2012, 48(11):1624-1632. 10.1016/j.ejca.2012.01.009, 22317953.
6. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005, 97(2):142-146. 10.1093/jnci/dji024, 15657344.
7. Cossentino MJ, Wong RK. Barrett's esophagus and risk of esophageal adenocarcinoma. Semin Gastrointest Dis 2003, 14(3):128-135.
8. Barber M, Fitzgerald RC, Caldas C. Familial gastric cancer - aetiology and pathogenesis. Best Pract Res Clin Gastroenterol 2006, 20(4):721-734.
9. Gao Y, Hu N, Han X, Giffen C, Ding T, Goldstein A, Taylor P. Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China. BMC Cancer 2009, 9(1):269. 10.1186/1471-2407-9-269, 2729777, 19656375.
10. Chen M-J, Wu D-C, Ko Y-C, Chiou Y-Y. Personal history and family history as a predictor of gastric cardiac adenocarcinoma risk: a case-control study in Taiwan. Am J Gastroenterol 2004, 99(7):1250-1257. 10.1111/j.1572-0241.2004.30872.x, 15233662.
11. Zhang ZF, Kurtz RC, Sun M, Karpeh M, Yu GP, Gargon N, Fein JS, Georgopoulos SK, Harlap S. Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors. Cancer Epidemiol Biomarkers Prev 1996, 5(10):761-768.
12. Dhillon PK, Farrow DC, Vaughan TL, Chow W-H, Risch HA, Gammon MD, Mayne ST, Stanford JL, Schoenberg JB, Ahsan H, et al. Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer 2001, 93(1):148-152. 10.1002/ijc.1294, 11391635.
13. Ji J, Hemminki K. Familial risk for esophageal cancer: an updated epidemiologic study from Sweden. Clin Gastroenterol Hepatol 2006, 4(7):840-845. 10.1016/j.cgh.2006.03.005, 16678496.
14. Hemminki K, Sundquist J, Ji J. Familial risk for gastric carcinoma: an updated study from Sweden. Br J Cancer 2007, 96(8):1272-1277. 10.1038/sj.bjc.6603722, 2360151, 17406355.
15. Wu AH, Wan P, Bernstein L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control 2001, 12(8):721-732. 10.1023/A:1011290704728, 11562112.
16. Wu AH, Crabtree JE, Bernstein L, Hawtin P, Cockburn M, Tseng CC, Forman D. Role of Helicobacter pylori CagA + strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 2003, 103(6):815-821. 10.1002/ijc.10887, 12516104.
17. Wu AH, Tseng CC, Bernstein L. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer 2003, 98(5):940-948. 10.1002/cncr.11568, 12942560.
18. Cockburn MG, Wu AH, Bernstein L. Etiologic clues from the similarity of histology-specific trends in esophageal and lung cancers. Cancer Causes Control 2005, 16(9):1065-1074. 10.1007/s10552-005-5382-0, 16184472.
19. Wu AH, Tseng CC, Hankin J, Bernstein L. Fiber intake and risk of adenocarcinomas of the esophagus and stomach. Cancer Causes Control 2007, 18(7):713-722. 10.1007/s10552-007-9014-8, 17562192.
20. Duan L, Wu AH, Sullivan-Halley J, Bernstein L. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles county. Cancer Epidemiol Biomarkers Prev 2008, 17(1):126-134. 10.1158/1055-9965.EPI-07-0664, 18187391.
21. Pondugula K, Wani S, Sharma P. Barrett's esophagus and esophageal adenocarcinoma in adults: long-term GERD or something else?. Curr Gastroenterol Rep 2007, 9(6):468-474. 10.1007/s11894-007-0061-9, 18377797.
22. Falk GW. Barrett's esophagus. Gastroenterology 2002, 122(6):1569-1591. 10.1053/gast.2002.33427, 12016424.
23. Conio M, Lapertosa G, Blanchi S, Filiberti R. Barrett's esophagus: an update. Crit Rev Oncol Hematol 2003, 46(2):187-206. 10.1016/S1040-8428(02)00123-3, 12711361.
24. Su Z, Gay LJ, Strange A, Palles C, Band G, Whiteman DC, Lescai F, Langford C, Nanji M, Edkins S, et al. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet 2012, 44(10):1131-1136. 10.1038/ng.2408, 3459818, 22961001.
25. Chak A, Ochs-Balcom H, Falk G, Grady WM, Kinnard M, Willis JE, Elston R, Eng C. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiol Biomarkers Prev 2006, 15(9):1668-1673. 10.1158/1055-9965.EPI-06-0293, 16985029.
26. Juhasz A, Mittal SK, Lee TH, Deng C, Chak A, Lynch HT. Prevalence of Barrett esophagus in first-degree relatives of patients with esophageal adenocarcinoma. J Clin Gastroenterol 2011, 45(10):867-871. 10.1097/MCG.0b013e31821f44a8, 3189338, 21617543.
27. Chandanos E, Lagergren J. The mystery of male dominance in oesophageal cancer and the potential protective role of oestrogen. Eur J Cancer 2009, 45(18):3149-3155. 10.1016/j.ejca.2009.09.001, 19804965.
28. Brown LM, Devesa SS, Chow W-H. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008, 100(16):1184-1187. 10.1093/jnci/djn211, 2518165,2518165, 18695138.
29. Yang H, Sukocheva OA, Hussey DJ, Watson DI. Estrogen, male dominance and esophageal adenocarcinoma: is there a link?. World J Gastroenterol 2012, 18(5):393-400. 10.3748/wjg.v18.i5.393, 3270506, 22346245.
30. Awan AK, Iftikhar SY, Morris TM, Clarke PA, Grabowska AM, Waraich N, Watson SA. Androgen receptors may act in a paracrine manner to regulate oesophageal adenocarcinoma growth. Eur J Surg Oncol 2007, 33(5):561-568. 10.1016/j.ejso.2006.12.001, 17254742.
31. Bosland MC. Sex steroids and prostate carcinogenesis. Ann N Y Acad Sci 2006, 1089(1):168-176. 10.1196/annals.1386.040, 2821822, 17261765.
32. Colditz GA. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst 1998, 90(11):814-823. 10.1093/jnci/90.11.814, 9625169.
33. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000, 343(2):78-85. 10.1056/NEJM200007133430201, 10891514.
34. Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family-cancer database. Int J Cancer 2002, 99(2):260-266. 10.1002/ijc.10332, 11979442.
35. Plummer M, Franceschi S, Munoz N. Epidemiology of gastric cancer. IARC Sci Publ 2004, 157:311-326.
36. Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, Perez-Perez G, Taylor PR, Virtamo J, Albanes D. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst 2001, 93(12):937-941. 10.1093/jnci/93.12.937, 11416115.
37. Jackson L, Evers BM. Chronic inflammation and pathogenesis of GI and pancreatic cancers. Cancer Treat Res 2006, 130:39-65. 10.1007/0-387-26283-0_2, 16610702.
38. Hamacher R, Diersch S, Scheibel M, Eckel F, Mayr M, Rad R, Bajbouj M, Schmid RM, Saur D, Schneider G. Interleukin 1 beta gene promoter SNPs are associated with risk of pancreatic cancer. Cytokine 2009, 46(2):182-186. 10.1016/j.cyto.2009.01.005, 19251436.
39. Larsson SC, Giovannucci E, Wolk A. Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 2006, 131(4):1271-1283. 10.1053/j.gastro.2006.08.010, 17030196.
40. Love RR, Evans AM, Josten DM. The accuracy of patient reports of a family history of cancer. J Chronic Dis 1985, 38(4):289-293. 10.1016/0021-9681(85)90074-8, 3998045.
41. Firth D. Bias reduction of maximum likelihood estimates. Biometrika 1993, 80(1):27-38.